Cargando…

Potential for additional government spending on HIV/AIDS in 137 low-income and middle-income countries: an economic modelling study

BACKGROUND: Between 2012 and 2016, development assistance for HIV/AIDS decreased by 20·0%; domestic financing is therefore critical to sustaining the response to HIV/AIDS. To understand whether domestic resources could fill the financing gaps created by declines in development assistance, we aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Haakenstad, Annie, Moses, Mark W, Tao, Tianchan, Tsakalos, Golsum, Zlavog, Bianca, Kates, Jennifer, Wexler, Adam, Murray, Christopher J L, Dieleman, Joseph L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540601/
https://www.ncbi.nlm.nih.gov/pubmed/31036482
http://dx.doi.org/10.1016/S2352-3018(19)30038-4
_version_ 1783422657149009920
author Haakenstad, Annie
Moses, Mark W
Tao, Tianchan
Tsakalos, Golsum
Zlavog, Bianca
Kates, Jennifer
Wexler, Adam
Murray, Christopher J L
Dieleman, Joseph L
author_facet Haakenstad, Annie
Moses, Mark W
Tao, Tianchan
Tsakalos, Golsum
Zlavog, Bianca
Kates, Jennifer
Wexler, Adam
Murray, Christopher J L
Dieleman, Joseph L
author_sort Haakenstad, Annie
collection PubMed
description BACKGROUND: Between 2012 and 2016, development assistance for HIV/AIDS decreased by 20·0%; domestic financing is therefore critical to sustaining the response to HIV/AIDS. To understand whether domestic resources could fill the financing gaps created by declines in development assistance, we aimed to track spending on HIV/AIDS and estimated the potential for governments to devote additional domestic funds to HIV/AIDS. METHODS: We extracted 8589 datapoints reporting spending on HIV/AIDS. We used spatiotemporal Gaussian process regression to estimate a complete time series of spending by domestic sources (government, prepaid private, and out-of-pocket) and spending category (prevention, and care and treatment) from 2000 to 2016 for 137 low-income and middle-income countries (LMICs). Development assistance data for HIV/AIDS were from Financing Global Health 2018, and HIV/AIDS prevalence, incidence, and mortality were from the Global Burden of Disease study 2017. We used stochastic frontier analysis to estimate potential additional government spending on HIV/AIDS, which was conditional on the current government health budget and other finance, economic, and contextual factors associated with HIV/AIDS spending. All spending estimates were reported in 2018 US$. FINDINGS: Between 2000 and 2016, total spending on HIV/AIDS in LMICs increased from $4·0 billion (95% uncertainty interval 2·9–6·0) to $19·9 billion (15·8–26·3), spending on HIV/AIDS prevention increased from $596 million (258 million to 1·3 billion) to $3·0 billion (1·5–5·8), and spending on HIV/AIDS care and treatment increased from $1·1 billion (458·1 million to 2·2 billion) to $7·2 billion (4·3–11·8). Over this time period, the share of resources sourced from development assistance increased from 33·2% (21·3–45·0) to 46·0% (34·2–57·0). Care and treatment spending per year on antiretroviral therapy varied across countries, with an IQR of $284–2915. An additional $12·1 billion (8·4–17·5) globally could be mobilised by governments of LMICs to finance the response to HIV/AIDS. Most of these potential resources are concentrated in ten middle-income countries (Argentina, China, Colombia, India, Indonesia, Mexico, Nigeria, Russia, South Africa, and Vietnam). INTERPRETATION: Some governments could mobilise more domestic resources to fight HIV/AIDS, which could free up additional development assistance for many countries without this ability, including many low-income, high-prevalence countries. However, a large gap exists between available financing and the funding needed to achieve global HIV/AIDS goals, and sustained and coordinated effort across international and domestic development partners is required to end AIDS by 2030. FUNDING: The Bill & Melinda Gates Foundation.
format Online
Article
Text
id pubmed-6540601
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier B.V
record_format MEDLINE/PubMed
spelling pubmed-65406012019-06-03 Potential for additional government spending on HIV/AIDS in 137 low-income and middle-income countries: an economic modelling study Haakenstad, Annie Moses, Mark W Tao, Tianchan Tsakalos, Golsum Zlavog, Bianca Kates, Jennifer Wexler, Adam Murray, Christopher J L Dieleman, Joseph L Lancet HIV Article BACKGROUND: Between 2012 and 2016, development assistance for HIV/AIDS decreased by 20·0%; domestic financing is therefore critical to sustaining the response to HIV/AIDS. To understand whether domestic resources could fill the financing gaps created by declines in development assistance, we aimed to track spending on HIV/AIDS and estimated the potential for governments to devote additional domestic funds to HIV/AIDS. METHODS: We extracted 8589 datapoints reporting spending on HIV/AIDS. We used spatiotemporal Gaussian process regression to estimate a complete time series of spending by domestic sources (government, prepaid private, and out-of-pocket) and spending category (prevention, and care and treatment) from 2000 to 2016 for 137 low-income and middle-income countries (LMICs). Development assistance data for HIV/AIDS were from Financing Global Health 2018, and HIV/AIDS prevalence, incidence, and mortality were from the Global Burden of Disease study 2017. We used stochastic frontier analysis to estimate potential additional government spending on HIV/AIDS, which was conditional on the current government health budget and other finance, economic, and contextual factors associated with HIV/AIDS spending. All spending estimates were reported in 2018 US$. FINDINGS: Between 2000 and 2016, total spending on HIV/AIDS in LMICs increased from $4·0 billion (95% uncertainty interval 2·9–6·0) to $19·9 billion (15·8–26·3), spending on HIV/AIDS prevention increased from $596 million (258 million to 1·3 billion) to $3·0 billion (1·5–5·8), and spending on HIV/AIDS care and treatment increased from $1·1 billion (458·1 million to 2·2 billion) to $7·2 billion (4·3–11·8). Over this time period, the share of resources sourced from development assistance increased from 33·2% (21·3–45·0) to 46·0% (34·2–57·0). Care and treatment spending per year on antiretroviral therapy varied across countries, with an IQR of $284–2915. An additional $12·1 billion (8·4–17·5) globally could be mobilised by governments of LMICs to finance the response to HIV/AIDS. Most of these potential resources are concentrated in ten middle-income countries (Argentina, China, Colombia, India, Indonesia, Mexico, Nigeria, Russia, South Africa, and Vietnam). INTERPRETATION: Some governments could mobilise more domestic resources to fight HIV/AIDS, which could free up additional development assistance for many countries without this ability, including many low-income, high-prevalence countries. However, a large gap exists between available financing and the funding needed to achieve global HIV/AIDS goals, and sustained and coordinated effort across international and domestic development partners is required to end AIDS by 2030. FUNDING: The Bill & Melinda Gates Foundation. Elsevier B.V 2019-04-26 /pmc/articles/PMC6540601/ /pubmed/31036482 http://dx.doi.org/10.1016/S2352-3018(19)30038-4 Text en © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Haakenstad, Annie
Moses, Mark W
Tao, Tianchan
Tsakalos, Golsum
Zlavog, Bianca
Kates, Jennifer
Wexler, Adam
Murray, Christopher J L
Dieleman, Joseph L
Potential for additional government spending on HIV/AIDS in 137 low-income and middle-income countries: an economic modelling study
title Potential for additional government spending on HIV/AIDS in 137 low-income and middle-income countries: an economic modelling study
title_full Potential for additional government spending on HIV/AIDS in 137 low-income and middle-income countries: an economic modelling study
title_fullStr Potential for additional government spending on HIV/AIDS in 137 low-income and middle-income countries: an economic modelling study
title_full_unstemmed Potential for additional government spending on HIV/AIDS in 137 low-income and middle-income countries: an economic modelling study
title_short Potential for additional government spending on HIV/AIDS in 137 low-income and middle-income countries: an economic modelling study
title_sort potential for additional government spending on hiv/aids in 137 low-income and middle-income countries: an economic modelling study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540601/
https://www.ncbi.nlm.nih.gov/pubmed/31036482
http://dx.doi.org/10.1016/S2352-3018(19)30038-4
work_keys_str_mv AT haakenstadannie potentialforadditionalgovernmentspendingonhivaidsin137lowincomeandmiddleincomecountriesaneconomicmodellingstudy
AT mosesmarkw potentialforadditionalgovernmentspendingonhivaidsin137lowincomeandmiddleincomecountriesaneconomicmodellingstudy
AT taotianchan potentialforadditionalgovernmentspendingonhivaidsin137lowincomeandmiddleincomecountriesaneconomicmodellingstudy
AT tsakalosgolsum potentialforadditionalgovernmentspendingonhivaidsin137lowincomeandmiddleincomecountriesaneconomicmodellingstudy
AT zlavogbianca potentialforadditionalgovernmentspendingonhivaidsin137lowincomeandmiddleincomecountriesaneconomicmodellingstudy
AT katesjennifer potentialforadditionalgovernmentspendingonhivaidsin137lowincomeandmiddleincomecountriesaneconomicmodellingstudy
AT wexleradam potentialforadditionalgovernmentspendingonhivaidsin137lowincomeandmiddleincomecountriesaneconomicmodellingstudy
AT murraychristopherjl potentialforadditionalgovernmentspendingonhivaidsin137lowincomeandmiddleincomecountriesaneconomicmodellingstudy
AT dielemanjosephl potentialforadditionalgovernmentspendingonhivaidsin137lowincomeandmiddleincomecountriesaneconomicmodellingstudy